Official title and information are available only for Plus and Premium subscribers.
Patent Pending Protein kinase C inhibitors, such as ruboxistaurin, may potentially be beneficial in peripheral diabetic nephropathy.[16] The Protein kinase C activator ingenol mebutate, derived from the plant Euphorbia peplus, is FDA-approved for the treatment of actinic keratosis.
To see the additional information details please login and subscribe to a Plus or Premium account.
